TGFB1 and pemphigus foliaceus: In this study, we present the proof of concept for a design and preclinical application of a nebulization LNP-mediated gene silencing approach targeting TGFβ1 to inhibit the progression of PF in a bleomycin (BLM)-induced PF mouse model.